SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06833 SINCO PHARMA

Market Closed 01-30 16:08:02

0.170

-0.010

-5.56%

High0.171	Low0.160	Vol2.00M
Open0.171	D1 Closing0.180	Amplitude6.11%
Mkt Cap345.61M	Tradable Cap345.59M	Total Shares2.03B
T/O328.15K	T/O Rate0.10%	Tradable Shares2.03B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06833","market":"HK","secType":"STK","nameCN":"SINCO PHARMA","latestPrice":0.17,"timestamp":1769760482490,"preClose":0.18,"halted":0,"volume":2004000,"delay":0,"changeRate":-0.055555555555555455,"floatShares":2032890585,"shares":2032999999,"eps":0.020682,"marketStatus":"Market Closed","change":-0.01,"latestTime":"01-30 16:08:02","open":0.171,"high":0.171,"low":0.16,"amount":328152,"amplitude":0.061111,"askPrice":0.171,"askSize":120000,"bidPrice":0.17,"bidSize":116000,"shortable":0,"etf":0,"ttmEps":0.022195,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":7,"adr":0,"listingDate":1457539200000,"exchange":"SEHK","adjPreClose":0.18,"dividendRate":0.011765,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":27.22826087326471,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06833","defaultTab":"news","newsList":[{"id":"2603627877","title":"Investors Don't See Light At End Of Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Tunnel","url":"https://stock-news.laohu8.com/highlight/detail?id=2603627877","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603627877?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:54","pubTimestamp":1768438473,"startTime":"0","endTime":"0","summary":"With a price-to-earnings (or \"P/E\") ratio of 6.8x Sinco Pharmaceuticals Holdings Limited ( HKG:6833 ) may be sending...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6833/sinco-pharmaceuticals-holdings-shares/news/investors-dont-see-light-at-end-of-sinco-pharmaceuticals-hol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6833/sinco-pharmaceuticals-holdings-shares/news/investors-dont-see-light-at-end-of-sinco-pharmaceuticals-hol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","ISBC","BK1197","06833"],"gpt_icon":0},{"id":"2589386432","title":"Sinco Pharma Says Internal-Control Gaps Remedied After Review; Shares Slip 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589386432","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589386432?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:45","pubTimestamp":1765169102,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals  said it has completed remediation measures addressing deficiencies identified in an internal control review tied to a 2021 interest-free loan, according to a Dec. 05 Hong Kong bourse filing.Shares of the firm were down over 4% in Monday's midday trade.The company implemented revised connected-transaction procedures, strengthened fund management and payment approval policies, introduced petty cash controls, updated contract management steps, and formalised bank-account handling requirements.A follow-up review submitted concluded that the measures adequately address the previously identified gaps, according to the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06833","BK1197"],"gpt_icon":0},{"id":"1170000324","title":"Sinco Pharmaceuticals (06833) Announces Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1170000324","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170000324?lang=en_us&edition=fundamental","pubTime":"2025-12-01 16:46","pubTimestamp":1764578795,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (06833) released its monthly return, confirming no changes in its authorized share capital and issued shares for November 2025. The authorized share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"gpt_icon":0},{"id":"1187654274","title":"SINCO PHARMA (06833) Reports Interim Results with Shareholders' Profit of RMB 24.389 Million, Up 2.17% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1187654274","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187654274?lang=en_us&edition=fundamental","pubTime":"2025-08-27 17:02","pubTimestamp":1756285341,"startTime":"0","endTime":"0","summary":"SINCO PHARMA (06833) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of RMB 1.196 billion during the period, representing a decrease of 21.68%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"gpt_icon":0},{"id":"2562716171","title":"BRIEF-Sinco Pharmaceuticals Holdings Posts H1 Net Income Of RMB24.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562716171","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562716171?lang=en_us&edition=fundamental","pubTime":"2025-08-27 17:01","pubTimestamp":1756285319,"startTime":"0","endTime":"0","summary":"BRIEF-Sinco Pharmaceuticals Holdings Posts H1 Net Income Of RMB24.4 Mln\n\n\nAug 27 (Reuters) - Sinco Pharmaceuticals Holdings H1 EPS RMB 0.012.\n\nH1 revenue RMB 1,195.8 million\nH1 gross profit RMB 130.7 million\nH1 net income RMB 24.4 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nPLXCD7B33:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"gpt_icon":0},{"id":"1137310640","title":"SINCO PHARMA (06833) Proposes Appointment of Bai Zhizhong as Lead Independent Non-executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1137310640","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137310640?lang=en_us&edition=fundamental","pubTime":"2025-08-27 16:58","pubTimestamp":1756285106,"startTime":"0","endTime":"0","summary":"SINCO PHARMA (06833) announced that Ms. Jing Huan and Mr. Bai Zhizhong have been appointed as members of the nomination committee, effective from August 27, 2025. The company also proposes to appoint Mr. Bai Zhizhong as Lead Independent Non-executive Director, effective from August 27, 2025.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"gpt_icon":0},{"id":"2562871630","title":"Sinco Pharmaceuticals Holdings H1 Revenue RMB 9.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2562871630","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562871630?lang=en_us&edition=fundamental","pubTime":"2025-08-27 16:57","pubTimestamp":1756285045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nPLXCD7B33:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1197","06833"],"gpt_icon":0},{"id":"2562716303","title":"Sinco Pharmaceuticals Holdings H1 Gross Profit RMB 130.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2562716303","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562716303?lang=en_us&edition=fundamental","pubTime":"2025-08-27 16:57","pubTimestamp":1756285045,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nPLXCD7B33:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06833","BK1197"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinco-pharm.com","stockEarnings":[{"period":"1week","weight":-0.0659},{"period":"1month","weight":-0.0395},{"period":"3month","weight":-0.0957},{"period":"6month","weight":-0.2444},{"period":"1year","weight":-0.3254},{"period":"ytd","weight":-0.0395}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinco Pharmaceuticals Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive marketing, promotion and channel management service for imported pharmaceutical products and medical devices. The Company operates three segments. The Sale of Imported Pharmaceutical Products segment engages in marketing, promotion, channel management activities for the sale of improved human plasma-based pharmaceuticals, antibiotics and other pharmaceuticals focused on therapeutic areas and complementary to human plasma-based products and other categories. The Research and Manufacturing of Aesthetic Medicine segment engages in the research and development and manufacturing of aesthetic medicine. The Medical Beauty Services segment engages in the provision of medical beauty services through its subsidiary company. The Company conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.039713},{"month":2,"riseRate":0.555556,"avgChangeRate":0.12017},{"month":3,"riseRate":0.444444,"avgChangeRate":0.026939},{"month":4,"riseRate":0.1,"avgChangeRate":-0.087807},{"month":5,"riseRate":0.3,"avgChangeRate":-0.048869},{"month":6,"riseRate":0.2,"avgChangeRate":-0.079997},{"month":7,"riseRate":0.5,"avgChangeRate":0.07039},{"month":8,"riseRate":0.2,"avgChangeRate":-0.173894},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015219},{"month":10,"riseRate":0.6,"avgChangeRate":0.146368},{"month":11,"riseRate":0.4,"avgChangeRate":0.058607},{"month":12,"riseRate":0.7,"avgChangeRate":0.063452}],"exchange":"SEHK","name":"SINCO PHARMA","nameEN":"SINCO PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINCO PHARMA(06833) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINCO PHARMA,06833,SINCO PHARMA股票,SINCO PHARMA股票老虎,SINCO PHARMA股票老虎国际,SINCO PHARMA行情,SINCO PHARMA股票行情,SINCO PHARMA股价,SINCO PHARMA股市,SINCO PHARMA股票价格,SINCO PHARMA股票交易,SINCO PHARMA股票购买,SINCO PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINCO PHARMA(06833) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}